title: Cross-boundary cancer studies at the University of Tokyo: Shining a light in the darkness: what can we see?
authors: please contact Hideyuki Akaza, MD, Department of Strategic Investigation on Comprehensive Cancer Network, Research Center for Advanced Science and Technology, The University of Tokyo, 4-6-1 Komaba, Meguro-ku, Tokyo 153-8904 Japan. akazah@med.rcast.u-tokyo.ac.jp.
authors: Yohei
authors: Y
authors: Sasakawa
mesh_terms: D001208:Asia; D002681:China; D005060:Europe; D017048:Health Care Costs; D049668:History, 15th Century; D049669:History, 16th Century; D049672:History, 19th Century; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D019458:Insurance Coverage; D007391:International Cooperation; D007564:Japan; D007917:Leprostatic Agents / Q000627:therapeutic use; D007918:Leprosy / Q000188:drug therapy / Q000266:history; D008518:Medicine, East Asian Traditional / Q000191:economics; D009369:Neoplasms / Q000517:prevention & control; D063508:Social Discrimination; D013785:Thailand; D014481:United States
chemical_list: D007917:Leprostatic Agents
keywords: cancer control; cross-boundary cancer studies; medical education; non-governmental organizations; the University of Tokyo